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Methamphetamine (MA) use is becoming commonplace, and emergency physicians (EPs) are seeing 
patients with abuse-associated complications. Previous reports have described inhalational and 
intravenous routes. We present the second case of rectal MA abuse in the literature. Trans-rectal use 
is important for EPs to consider because ongoing absorption of massive quantities may be averted 
upon detection. Additionally, trans-rectal abuse risks anorectal trauma and vascular necrosis with 
colonic perforation.
[WestJEM. 2009;10:58-60.]
INTRODUCTION
Methamphetamine (MA) and chemically related 
compounds have become preeminent drugs of abuse. 
Internationally, MA use ranks second only to cannabis as 
the most commonly abused drug with 35 million users 
worldwide.1 In Canada reports have documented increasing 
popularity in addition to concomitant morbidity.2-4 A recent 
national survey estimates the lifetime incidence of any use to 
be 6% for all Canadians.5 MA use in the United States (U.S.) 
is similarly common. The 2005 U.S. National Survey on Drug 
Use and Health reported 10.4 million (4.3%) Americans aged 
12 or older had tried MA, while 1.3 million reported MA 
use in the last year and 512,000 in the past month.6 The MA 
problem is socially costly due to violence associated with 
its use, economic non-productivity of abusers, and the harm 
to individuals near labs from highly toxic by-products of 
manufacture.7 Emergency physicians (EPs) witness directly 
the tremendous impact on medical, trauma, and psychiatric 
care systems. One report estimates that 2.3% of emergency 
department (ED) visits are related to MA use.8,9 According 
to another recent assessment, abusers of MA, compared to 
abusers of cocaine, are more likely to require admission to a 
psychiatric unit and to have longer stays.10 
MA toxicity can occur via a variety of exposure 
routes. The most frequently cited forms are intranasal, oral, 
intravenous (IV), or inhaled.6 We present a case report 
of a patient who developed toxicity following a unique 
method of exposure. 
CAsE REPORT
A 30-year-old man was brought to the ED by paramedics 
from outside a gas station bathroom. Police had been called 
because the patient had been in the bathroom for an hour, 
and they had to forcibly open the door to release him. The 
patient admitted to taking a “large” amount of MA in addition 
to six beers. The patient reported racing thoughts and feeling 
anxious but denied chest pain, shortness of breath, nausea, 
vomiting, or suicidal ideation. The patient denied having any 
medical problems or medications. 
The patient was awake and conversant, but also agitated 
and restless. His vital signs were pulse 145 beats per minute, 
blood pressure 145/ 77 mmHg, oral temperature 37.2°Celsius, 
respiratory rate at 22 breaths per minute, pulse oximetry 97% 
on room air and a normal blood glucose. His physical exam 
revealed 4mm mydriasis without nystagmus and minimal 
reaction to light. He had positive bowel sounds and was not 
diaphoretic. The rest of his lung, heart, and extremity exam 
was unremarkable. An ECG demonstrated a sinus tachycardia, 
with no ischemic changes and normal intervals. Initial 
laboratory tests included electrolytes, complete blood count, 
liver function tests, and cardiac markers, with the following 
abnormal results: creatinine 1.3 mg/dL, creatinine kinase 
1779 IU/L and troponin I of 0.11 ng/mL. A urine and serum 
toxicology screening was positive only for MA and alcohol.
The patient became more manageable over a period 
of four hours and asked to use the restroom. Appearing 
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granted. He then disappeared for an hour and was later found 
in another part of the hospital in a decompensated state 
with tachycardia, agitation and altered mental status. The 
patient was restrained, sedated and admitted to the hospital. 
Tachycardia and agitation persisted despite over three liters 
of IV normal saline and almost 50 mg of IV lorazepam over 
the next 12 hours. Finally, the patient had a bowel movement 
productive of a tampon. In the morning, the patient’s mental 
status had resolved. Upon further questioning, the patient 
admitted to inserting a MA-soaked tampon trans-rectally. The 
tampon was not tested for MA. He subsequently signed out 
against medical advice rather abruptly and further information 
regarding his past MA use could not be obtained.
DIsCUssION 
To our knowledge, we present the first report of a case 
of MA toxicity after intentional rectal administration with a 
tampon. Awareness of this novel usage is important for EPs 
as prolonged exposure to MA can potentially be avoided by 
specific questioning and careful physical exam. 
Routes of MA administration are varied, with prior reports 
of exposure via nasal insufflation, IV administration, ingestion 
of liquid formulations, and a single case report of intravaginal 
exposure.11 Our report of MA toxicity demonstrates a novel 
delivery method – intentional rectal administration with a 
tampon. The rectal bioavailability of MA is not well-defined, 
but enteric absorption via the oral route is good with relatively 
low protein binding (<20%). The volume of distribution is 
approximately 4L/kg.12 Similar to the oral route, absorption of 
MA across rectal mucosa may provide significant quantities 
of MA to be delivered rapidly into the systemic circulation via 
the anorectal-venous circulation. Though the literature lacks 
data regarding relative speed of onset via different routes, 
a popular website dedicated to MA subculture reports the 
following times for various routes: oral (20-30 minutes); intra-
nasal (3-5 minutes); smoking (7-10 seconds); trans-rectal (3-5 
minutes); and IV (15-30 seconds).13
Complications of intestinal absorption to MA have been 
reported primarily in the context of both body packers and 
stuffers. Body packers, often referred to as “mules,” swallow 
packets (such as condoms) containing large quantities of drugs 
as a transport method with the expectation of subsequently 
defecating the packets intact. Body stuffers, on the other hand, 
swallow drugs to avoid capture while in possession of drugs. 
The former group experiences toxicity when transport vehicles 
fail and inadvertently release drugs into the gastrointestinal 
tract. The latter group absorbs drugs as a result of haphazard 
packaging and rapid consumption of the drug. The occurrence 
of ischemic bowel after systemically administered cocaine 
or ergotamine use, secondary to mesenteric vasoconstriction, 
is well documented. There have also been at least four case 
reports of ischemic bowel after MA use.14 The application of 
methamphetamine directly to rectal mucosa likely has local 
vasoconstrictive effects, making rectal ischemia and necrosis a 
potential complication. 
A recognized problem with rectal administration is 
leakage of the mixture after dosing; this is discussed on 
websites dedicated to the MA use subculture.15 Presumably, 
the tampon used by this patient was intended to prevent 
such leakage. Our patient seemed to experience delayed and 
possibly recurrent toxicity from this route of administration, 
possibly due to a delayed-release effect of using a tampon. 
Cantrell et al.16 have recently reported a similar case of a 
woman who suffered toxicity following transrectal MA use. 
However, their patient experienced a more acute onset and 
resolution of symptoms consistent with direct instillation of 
liquid solution. Additional information and case reports of 
these types of exposures may help clarify whether the time-
course and complications of anorectal exposure to MA are 
distinct from other routes of exposure. 
CONCLUsION
Use of MA will likely increase, requiring EPs to manage 
multiple patients with sympatho-mimetic toxidromes, some of 
them severe. Epidemiologic data suggest that MA use will not 
wane like PCP and LSD. The users of this drug are inventive, 
and almost no method or route of administration goes untested. 
As this case highlights, the EP should specifically question 
patients about the route of administration, and perhaps include 
a rectal exam for patients suspected of MA toxicity, or at least 
those with recurrent or prolonged intoxication. 
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